XML 28 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation
6 Months Ended
Jun. 28, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION
Employee Share Purchase Plan
At our 2015 Annual Meeting of Shareholders, which was held on May 7, 2015, our shareholders approved an amendment to our Employee Share Purchase Plan to increase the number of shares of our common stock reserved for issuance under the plan from 4,200,000 to 4,450,000.
1995 Stock Incentive Plan
Also at our 2015 Annual Meeting of Shareholders, our shareholders approved an amendment to our 1995 Stock Incentive Plan (the “1995 Plan”) to increase the number of shares of our common stock reserved for issuance under the plan from 11,250,000 to 11,500,000.
The following table sets forth certain information regarding the 1995 Plan:
 
June 28,
2015
Shares available for grant
1,716,842

Shares of common stock reserved for issuance pursuant to outstanding exercisable securities
3,391,964


The following table sets forth certain information regarding all options outstanding and exercisable:
 
June 28, 2015
 
Options
Outstanding
 
Options
Exercisable
Number
1,005,953

 
311,567

Weighted average exercise price
$
69.25

 
$
53.84

Aggregate intrinsic value
$ 16.2 million

 
$ 9.8 million

Weighted average remaining contractual term
5.3 years

 
3.7 years


The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
 
June 28, 2015
 
RSUs Nonvested
 
RSUs Expected
to Vest
Number
669,169

 
584,755

Weighted average grant date per share fair value
$
73.74

 
$
72.97

Aggregate intrinsic value
$ 56.8 million

 
$ 49.7 million

Weighted average remaining term to vest
1.6 years

 
1.5 years


As of June 28, 2015, unrecognized stock-based compensation related to outstanding, but unvested stock options and RSUs was $50.7 million, which will be recognized over the weighted average remaining vesting period of 1.9 years.
Stock-Based Compensation Expense
Our stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):
 
Thirteen Weeks Ended
 
Twenty-Six Weeks Ended
 
June 28,
2015
 
June 29,
2014
 
June 28,
2015
 
June 29,
2014
Cost of sales
$
797

 
$
857

 
$
1,589

 
$
1,583

Research and development
659

 
713

 
1,289

 
1,330

Selling, general and administrative
3,089

 
4,253

 
7,616

 
8,048

Total stock-based compensation
$
4,545

 
$
5,823

 
$
10,494

 
$
10,961